# Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

> **NCT01424397** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 70 (actual)

## Conditions studied

- Rhinitis

## Interventions

- **DRUG:** SB-705498
- **DRUG:** FP
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01424397
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-14
- **Primary completion:** 2011-07-07
- **Final completion:** 2011-07-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424397, "Intranasal SB-705498 in Allergic Rhinitis (AR) Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01424397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*